Heart News and Research

RSS

Transcendental Meditation may be effective in reducing BP and psychological distress

"The Transcendental Meditation Program, a widely-used standardized program to reduce stress, showed significant decreases in blood pressure and improved mental health in young adults at risk for hypertension," said David Haaga, PhD, co-author of the study and professor of psychology at American University in Washington, D.C.

18 Nov 2009

Amsterdam Molecular Therapeutics provides third-quarter 2009 business updates

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today provides its non-audited business update in compliance with the EU transparency directive. This report summarizes material events and AMT's financial position for the third quarter of 2009.

18 Nov 2009

GRK2 inhibition protects against chronic heart failure

Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion, according to two studies conducted at the Center for Translational Medicine at Thomas Jefferson University. The studies will be presented at the American Heart Association Scientific Sessions 2009 in Orlando, Fla.

18 Nov 2009

Study examines link between folic acid and cancer incidence

Patients with heart disease in Norway, a country with no fortification of foods with folic acid, had an associated increased risk of cancer and death from any cause if they had received treatment with folic acid and vitamin B12, according to a study in the November 18 issue of JAMA.

18 Nov 2009

Sildenafil improves heart function in youngsters with single ventricle congenital heart disease

Heart function significantly improved in children and young adults with single ventricle congenital heart disease who have had the Fontan operation following treatment with sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, say researchers from The Children's Hospital of Philadelphia.

18 Nov 2009

Review of the results of Phase 2b clinical trial on PASCAL announced

ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx’s compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.

18 Nov 2009

Combination of night work, overtime and shortened sleep can increase risk of stroke and heart disease

A new study published in the current issue of Archives of Environmental & Occupational Health (vol. 64, No. 3) shows that this combination of night work, overtime and shortened sleep can contribute to the development among police officers of the metabolic syndrome, a combination of unhealthful factors that increase the risk of cardiovascular disease (CVD), primarily heart disease and stroke.

18 Nov 2009

First gene expression test for coronary artery disease

The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain.

18 Nov 2009

Quit and Stay Quit Monday, a tobacco-free campus initiative

plan can help them stay quit for good! Each Monday following the national quit day, smokers and relapsers can check in with local and national quitlines, counselors, family and friends to strengthen their commitment to a smoke-free life.

18 Nov 2009

Transplanting people's own stem cells into heart muscle lessens pain and improves ability to walk

The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells.

18 Nov 2009

Drug therapy offers substantial cost savings than angioplasty

Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD.

18 Nov 2009

Electronic cigarettes, a viable and much-needed alternative to combustible tobacco

The Electronic Cigarette Association (ECA) today urged decision-makers to seek alternatives to combustible tobacco that reduce Americans’ exposure to the multitude of harmful chemicals and toxins found in cigarettes.

18 Nov 2009

Global Alliance for Chronic Diseases announces targets

The Global Alliance for Chronic Diseases (GACD) on Monday outlined plans "to invest tens of millions of dollars in heart and lung disease studies in a battle against a global epidemic of chronic disease," over five years, Reuters reports.

17 Nov 2009

American Heart Association supports ‘Healthy Choices for Healthy Children legislation'

The American Heart Association is joining efforts to decrease and prevent childhood obesity through legislation that is being introduced today in the Ohio Senate and Ohio House of Representatives. The

17 Nov 2009

World Heart, LaunchPoint Technologies sign license agreements

World Heart Corporation (WorldHeart) announced today that it has finalized assignment and exclusive license agreements with LaunchPoint Technologies Inc., (LPT) Goleta, California, and Carnegie Mellon University (CMU), Pittsburgh, Pennsylvania for its next-generation minimally invasive blood pump, the MiVAD. The MiVAD(TM) is designed to provide partial cardiac support between 2-4 liters per minute to less sick heart failure patients than those served by existing full-support Left Ventricular Assist Devices (LVADs).

17 Nov 2009

ProVation MD software chosen for cardiology procedure documentation at Creighton University Medical Center

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Creighton University Medical Center has selected ProVation® MD software for Cardiology procedure documentation and coding. The software will be used to document and code catheterization cases at The Cardiac Center of Creighton University.

17 Nov 2009

Abbott and BG Medicine announce a development and commercialization agreement for galectin-3 biomarker

Abbott and BG Medicine, Inc. today announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott's ARCHITECT immunochemistry instrument platform, specifically the company's i1000SR and i2000SR instruments. The agreement grants Abbott a license to BG Medicine's intellectual property related to galectin-3.

17 Nov 2009

Heart News and Research

Transcendental Meditation may be effective in reducing BP and psychological distress

Amsterdam Molecular Therapeutics provides third-quarter 2009 business updates

GRK2 inhibition protects against chronic heart failure

Study examines link between folic acid and cancer incidence

Sildenafil improves heart function in youngsters with single ventricle congenital heart disease

Review of the results of Phase 2b clinical trial on PASCAL announced

Combination of night work, overtime and shortened sleep can increase risk of stroke and heart disease

First gene expression test for coronary artery disease

Quit and Stay Quit Monday, a tobacco-free campus initiative

Transplanting people's own stem cells into heart muscle lessens pain and improves ability to walk

Drug therapy offers substantial cost savings than angioplasty

Electronic cigarettes, a viable and much-needed alternative to combustible tobacco

Global Alliance for Chronic Diseases announces targets

American Heart Association supports ‘Healthy Choices for Healthy Children legislation'

World Heart, LaunchPoint Technologies sign license agreements

ProVation MD software chosen for cardiology procedure documentation at Creighton University Medical Center

Abbott and BG Medicine announce a development and commercialization agreement for galectin-3 biomarker

Genzyme and Isis Pharmaceuticals announce phase 3 study data of mipomersen

Neuralstem provides financial and business updates for third-quarter 2009

Non-clinical data from Cytokinetics' smooth muscle contractility program presented

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News